Elizabeth Weesner; Hosain Ghassemi; Iryna Salapenka; Jaya Sri Konakanchi; Gregory Maggio; Sethi, R. Injection Site Reaction to Extended-Release Buprenorphine (Sublocade®) for Opioid Use Disorder Fourteen Days After Administration. kjm 2022, 15 (2), 302-304. https://doi.org/10.17161/kjm.vol15.17931.